KMT2A and Chordoid Meningioma: Mixed-lineage leukemia 1/Lysine (K)-specific MethylTransferase 2 (MLL/KMT2) mutation has been identified in WHO grade 2 chordoid meningioma, associated with NF2 mutations and with worse prognosis [46].